Nicholas Company, Inc. Covetrus, Inc. Transaction History

Nicholas Company, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$13.8 - $20.82 $5.33 Million - $8.04 Million	-386,000 Closed	0 $0
Q1 2022 Feb 13, 2024	BUY	$15.96 - $18.87 $6.16 Million - $7.28 Million	386,000 New	386,000 $6.48 Million
Q1 2022 May 11, 2022	BUY	$15.96 - $18.87 $6,224 - $7,359	390 Added 0.1%	386,000 $6.48 Million
Q4 2021 Feb 11, 2022	BUY	$16.79 - $20.37 $543,660 - $659,580	32,380 Added 9.17%	385,610 $7.7 Million
Q3 2021 Nov 15, 2021	BUY	$18.14 - $27.03 $1.22 Million - $1.81 Million	67,105 Added 23.45%	353,230 $6.41 Million
Q2 2021 Aug 12, 2021	BUY	$25.24 - $30.86 $692,711 - $846,952	27,445 Added 10.61%	286,125 $7.73 Million
Q1 2021 May 14, 2021	BUY	$28.29 - $39.89 $291,104 - $410,468	10,290 Added 4.14%	258,680 $7.75 Million
Q4 2020 Feb 10, 2021	BUY	$24.45 - $31.59 $6.07 Million - $7.85 Million	248,390 New	248,390 $7.14 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Company, Inc. with notifications on news.